Related Experiment Video
Updated: Sep 24, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Putative therapeutic impacts of cardiac CTRP9 in ischaemia/reperfusion injury
Seyyed-Reza Sadat-Ebrahimi1, Hassan Amini2,3, Reza Rahbarghazi3,4
1Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Insights
C1q/tumour necrosis factor-related proteins (CTRPs), particularly CTRP9, show promise for treating cardiac ischaemia/reperfusion injury (IRI). Understanding CTRP9
Area of Science:
- Biochemistry
- Cardiology
- Molecular Biology
Background:
- C1q/tumour necrosis factor-related proteins (CTRPs) are gaining attention for metabolic and anti-inflammatory functions.
- CTRPs act as novel adipo/cardiokines involved in cardiovascular disease pathogenesis.
Purpose of the Study:
- To review recent findings on the therapeutic effects and mechanisms of CTRP9.
- To explore CTRP9's role in cardiac ischaemia/reperfusion injury (IRI).
Main Methods:
- Literature review of CTRP9 research.
- Analysis of CTRP9 signaling pathways.
- Discussion of CTRP9's relationship with IRI.
Main Results:
- CTRP9 exhibits significant therapeutic potential in cardiac IRI.
- CTRP9 signaling pathways are intricately linked to IRI pathogenesis.
- Multiple underlying mechanisms of CTRP9 in IRI are being elucidated.
Conclusions:
- CTRP9 is a promising therapeutic target for cardiac IRI.
- Further research into CTRP9 mechanisms can guide IRI treatment strategies.
- Understanding CTRP9's role may alleviate pathological consequences of IRI.
Abstract:
Recently, cytokines belonging to C1q/tumour necrosis factor-related proteins (CTRPs) superfamily have attracted increasing attention due to multiple metabolic functions and desirable anti-inflammatory effects. These various molecular effectors exhibit key roles upon the onset of cardiovascular diseases, making them novel adipo/cardiokines. This review article aimed to highlight recent findings correlated with therapeutic effects and additional mechanisms specific to the CTRP9, particularly in cardiac ischaemia/reperfusion injury (IRI). Besides, the network of the CTPR9 signalling pathway and its possible relationship with IRI were discussed. Together, the discovery of all involved underlying mechanisms could shed light to alleviate the pathological sequelae after the occurrence of IRI.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020